Advertisement Amarin selects BioClinica eClinical suite - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Amarin selects BioClinica eClinical suite

Amarin has selected BioClinica's eClinical suite to capture and manage clinical data for their Phase IIIb cardiology clinical trial.

The suite includes electronic data capture (EDC) and data management, interactive response technology (IRT/IVR/IWR), and clinical trial management (CTMS) solutions.

The Phase IIIb cardiology study is planned to involve approximately 300 sites and 8,000 patients globally.

BioClinica eClinical solutions president Peter Benton said that Amarin’s clinical development team selected an integrated solution that will share essential clinical data while streamlining their clinical data and site management processes.